Aurobindo gets EDQM nod for domperidone and domperidone maleate
July 21st, 2005, 19:14:34 hrs IST
Symposium on patient safety and pharmacists to be held on July 27
July 21st, 2005, 16:59:13 hrs IST
Technology transfer conference on July 29-30
July 21st, 2005, 16:53:50 hrs IST
NICB acquires Ocimum\'s Biotracker LIMS
July 15th, 2005, 20:02:52 hrs IST
Ranbaxy gets FDA tentative approval for zidovudine generic
July 15th, 2005, 19:56:03 hrs IST

Shantha Biotech introduces DTPH combination vaccine
Glenmark’s Oglemilast gets FDA approval for clinical trial

‘Activated recombinant factor VII acts like a targeted missile’
Professor Uri Martinowitz, the Chief Advisor to the Israeli defense forces in the field of hemorrhage control, and he is a member of the Israeli defense force trauma advisory board. He has acted as a consultant and received research support and honoraria from Novo Nordisk Pharmaceuticals. Dr Martinowitz speaks to Sapna Dogra about NovoSeven, its development and advantages.